http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105092490-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-78 |
| filingDate | 2014-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105092490-B |
| titleOfInvention | Actrapid monotard and the like or conjugate Bioactivity measuring method |
| abstract | The present invention relates to a kind of actrapid monotards and the like, including Semilente Insulin such as insulin aspart (Insulin aspart), insulin lispro (Insulin Lispro), glulisine (InsulinGlulisine)；Protamine zine insulin such as insulin glargine (Insulin glargine), insulin detemir (Insulin Detemir), moral paddy insulin (Insulin Degludec) and modification conjugate such as Pegylation insulin and the like PEG-Lispro(PEG conjugated insulin lispro) and PEG-Insulin(PEG conjugated des B30-insulin) cell in vitro method estimation of biological potency method and its application.The invention after external evoked lipoblast, using glucose in the culture solution of determination of glucose oxidase fat cell through the consumption under insulin action, calculates corresponding biological insulin potency using male rat PECTORAL LIMB SKELETON. |
| priorityDate | 2014-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 123.